–
Greenwich LifeSciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.60
FY22:
−8.04
FY23:
−9.33
FY24:
−17.6
FY25:
−19.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.59
FY22:
−8.04
FY23:
−9.32
FY24:
–
FY25:
−19.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.57
FY22:
−7.83
FY23:
−8.89
FY24:
–
FY25:
−19.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−4.57
FY22:
−7.83
FY23:
−8.89
FY24:
−17.4
FY25:
−19.4
All amounts in millions USD